Lifeboat Foundation

Ultrasound imaging is a safe and noninvasive window into the body’s workings, providing clinicians with live images of a patient’s internal organs. To capture these images, trained technicians manipulate ultrasound wands and probes to direct sound waves into the body. These waves reflect back out to produce high-resolution images of a patient’s heart, lungs, and other deep organs.

Currently, ultrasound imaging requires bulky and specialized equipment available only in hospitals and doctor’s offices. But a new design by MIT engineers might make the technology as wearable and accessible as buying Band-AIDS at the pharmacy.

Continue reading “Engineers develop stickers that can see inside the body” »

At the beginning of the COVID-19 pandemic, car manufacturing companies such as Ford quickly shifted their production focus from automobiles to masks and ventilators.

To make this switch possible, these companies relied on people working on an assembly line. It would have been too challenging for a robot to make this transition because robots are tied to their usual tasks.

Continue reading “How to help assembly-line robots shift gears and pick up almost anything” »

A water-activated disposable paper battery is presented in a proof-of-principle study in Scientific Reports. The authors suggest that it could be used to power a wide range of low-power, single-use disposable electronics—such as smart labels for tracking objects, environmental sensors and medical diagnostic devices—and minimize their environmental impact.

The battery, devised by Gustav Nyström and colleagues, is made of at least one cell measuring one centimeter squared and consisting of three inks printed onto a rectangular strip of paper. Sodium chloride salt is dispersed throughout the strip of paper and one of its shorter ends has been dipped in wax. An ink containing graphite flakes, which acts as the positive end of the battery (cathode), is printed onto one of the flat sides of the paper while an ink containing zinc powder, which acts as the negative end of the battery (anode), is printed onto the reverse side of the paper. Additionally, an ink containing graphite flakes and carbon black is printed on both sides of the paper, on top of the other two inks. This ink connects the positive and negative ends of the battery to two wires, which are located at the wax-dipped end of the paper.

When a small amount of water is added, the salts within the paper dissolve and charged ions are released. These ions activate the battery by dispersing through the paper, resulting in zinc in the ink at the negative end of the battery releasing electrons. Attaching the wires to an electrical device closes the circuit so that electrons can be transferred from the negative end—via the graphite and carbon black-containing ink, wires and device—to the positive end (the graphite-containing ink) where they are transferred to oxygen in the surrounding air. These reactions generate an electrical current that can be used to power the device.

A novel bioremediation technology for cleaning up per-and polyfluoroalkyl substances, or PFAS, chemical pollutants that threaten human health and ecosystem sustainability, has been developed by Texas A&M AgriLife researchers. The material has potential for commercial application for disposing of PFAS, also known as “forever chemicals.”

Published July 28 in Nature Communications, the research was a collaboration of Susie Dai, Ph.D., associate professor in the Texas A&M Department of Plant Pathology and Microbiology, and Joshua Yuan, Ph.D., chair and professor in Washington University in St. Louis Department of Energy, Environmental and Chemical Engineering, formerly with the Texas A&M Department of Plant Pathology and Microbiology.

Removing PFAS contamination is a challenge

Continue reading “New bioremediation material can clean ‘forever chemicals’” »

Dr. Arye Elfenbein, MD, PhD, is the Co-Founder of Wildtype (https://www.wildtypefoods.com/), a biotechnology company which produces cultured seafood (with a focus on cultivated Pacific salmon) from fish cells, sustainably and cost effectively, with the nutritional benefits, but without common contaminants such as mercury, microplastics, antibiotics, or pesticides, and without relying on commercial fishing or fish farming.

Born in Israel and raised in Australia, Dr. Elfenbein combines his deep passion for medicine and unique childhood connection to the ocean to fuel Wildtype’s health and environmental mission.

Continue reading “Dr. Arye Elfenbein, MD, PhD — Co-Founder, Wildtype — Building A Better Food System” »

Dr. Amber Salzman, Ph.D. is Chief Executive Officer and Director of Epic Bio (https://epic-bio.com/), a fascinating therapeutic epigenome editing startup, developing therapies to modulate gene expression at the level of the epigenome, which just recently emerged from stealth mode with a $55 million funding round.

Dr. Salzman has more than 30 years of experience in the pharmaceuticals industry. Before joining Epic Bio, Dr. Salzman served as the president and CEO of Ohana Biosciences, pioneering the industry’s first sperm biology platform. Before Ohana, she served as the president and CEO of Adverum Biotechnologies and was a co-founder of Annapurna, SAS, where she served as President and CEO before its merger with Avalanche Biotechnologies to become Adverum. In that role, she saw the company’s stock price double.

Continue reading “Dr. Amber Salzman, PhD — CEO & Director, Epic Bio — Editing The Epigenome To Treat Complex Diseases” »

Autism spectrum disorder (ASD) is a neurological and developmental condition that affects how humans communicate, learn new things and behave. Symptoms of ASD can include difficulties in interacting with others and adapting to changes in routine, repetitive behaviors, irritability and restricted or fixated interests for specific things.

While symptoms of autism can emerge at any age, the first signs generally start to show within the first two years of a child’s life. People with ASD can encounter numerous challenges, which can be addressed through support services, talk therapy and sometimes medication.

To this day, neuroscientists and medical researchers have not identified the primary causes of ASD. Nonetheless, past findings suggest that it could be caused by the interaction of specific genes with environmental factors.

In our latest article, our Divisional Chief Nurse, Clare, discusses the social effects of friendships for people with learning disabilities and/or autism and the importance of those friendships. She also discusses how COVID-19 and the different restrictions have affected people with learning disabilities and/or autism and how best to support them.

MRI, electroencephalography (EEG) and magnetoencephalography have long served as the tools to study brain activity, but new research from Carnegie Mellon University introduces a novel, AI-based dynamic brain imaging technology which could map out rapidly changing electrical activity in the brain with high speed, high resolution, and low cost. The advancement comes on the heels of more than thirty years of research that Bin He has undertaken, focused on ways to improve non-invasive dynamic brain imaging technology.

Brain electrical activity is distributed over the three-dimensional brain and rapidly changes over time. Many efforts have been made to image brain function and dysfunction, and each method bears pros and cons. For example, MRI has commonly been used to study brain activity, but is not fast enough to capture brain dynamics. EEG is a favorable alternative to MRI technology however, its less-than-optimal spatial resolution has been a major hindrance in its wide utility for imaging.

Continue reading “Advancing dynamic brain imaging with AI” »